Ortho Clinical Diagnostics Holdings plc (OCDX)
$17.63
As on 26-May-2022 16:00EDT
Market cap
$4,191 Mln
Revenue (TTM)
$2,036 Mln
P/E Ratio
--
P/B Ratio
9.5
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
13.6
-
Debt to Equity
4.9
-
Book Value
$--
-
EPS
$-0
-
Face value
--
-
Shares outstanding
237,735,008
5 Years Aggregate
CFO
$613.30 Mln
EBITDA
$1,808.90 Mln
Net Profit
$-788.20 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Ortho Clinical Diagnostics Holdings (OCDX)
| -17.6 | -2.2 | -2.5 | -12.2 | -- | -- | -- |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Ortho Clinical Diagnostics Holdings (OCDX)
Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are... used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey. As of May 27, 2022, Ortho Clinical Diagnostics Holdings plc operates as a subsidiary of Quidel Corporation. Read more
-
Chairman & CEO
Mr. Christopher Michael Smith
-
Chairman & CEO
Mr. Christopher Michael Smith
-
Headquarters
Raritan, NJ
-
Website
FAQs for Ortho Clinical Diagnostics Holdings (OCDX)
What is the current share price of Ortho Clinical Diagnostics Holdings plc (OCDX) Today?
The share price of Ortho Clinical Diagnostics Holdings plc (OCDX) is $17.63 (NASDAQ) as of 26-May-2022 16:00 EDT. Ortho Clinical Diagnostics Holdings plc (OCDX) has given a return of -12.24% in the last 1 years.
What is the current PB & PE ratio of Ortho Clinical Diagnostics Holdings plc (OCDX)?
Since, TTM earnings of Ortho Clinical Diagnostics Holdings plc (OCDX) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2021 |
-89.81 |
11.88 |
2020 |
-- |
-- |
2019 |
-- |
-- |
2018 |
-- |
-- |
2017 |
-- |
-- |
What is the 52 Week High and Low of Ortho Clinical Diagnostics Holdings plc (OCDX)?
The 52-week high and low of Ortho Clinical Diagnostics Holdings plc (OCDX) are Rs -- and Rs -- as of 06-Sep-2026.
What is the market cap of Ortho Clinical Diagnostics Holdings plc (OCDX)?
Ortho Clinical Diagnostics Holdings plc (OCDX) has a market capitalisation of $ 4,191 Mln as on 26-May-2022. As per SEBI classification, it is a Small Cap company.
Should I invest in Ortho Clinical Diagnostics Holdings plc (OCDX)?
Before investing in Ortho Clinical Diagnostics Holdings plc (OCDX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.